FEROZ financials Ferozsons Laboratories Limited
Ferozsons Laboratories Limited (FEROZ) has 5 financial years on file, from the year to 30 Jun 2022. The latest, the year to 30 Jun 2026 earned Rs 14.97 a share on sales of Rs 15.8 bn. 5 quarters are listed below the years.
Results by financial year
Company accounts as filed. Earnings per share are on today’s share count where a split or bonus issue came later. Years to 30 June. 5 years and 5 of the last 8 quarters.
Earnings per share by financial year
| Year | Earnings per share (Rs) | Sales | Gross margin | Net profit as a share of sales | Change in earnings per share on the year before |
|---|---|---|---|---|---|
| Year to 30 Jun 2026 | 14.97 | Rs 15.8 bn | 42.1% | 4.1% | +23.2% |
| Year to 30 Jun 2025 | 12.15 | Rs 13.9 bn | 41.3% | 3.8% | +32.1% |
| Year to 30 Jun 2024 | 9.20 | Rs 12.7 bn | 38.9% | 3.2% | +111.5% |
| Year to 30 Jun 2023 | 4.35 | Rs 9.9 bn | 38.6% | 1.9% | -63.2% |
| Year to 30 Jun 2022 | 11.83 | Rs 7.8 bn | 45.1% | 6.6% | — |
Results by quarter
5 of the last 8 quarters. The fourth quarter is filed only inside the annual accounts.
| Quarter | Earnings per share (Rs) | Sales | Profit after tax | Net profit as a share of sales | Change on the same quarter a year before |
|---|---|---|---|---|---|
| Quarter to 30 Sep 2026 | 5.05 | Rs 4.8 bn | Rs 219.6 m | 4.6% | +20.2% |
| Quarter to 31 Mar 2026 | 3.46 | Rs 3.7 bn | Rs 150.3 m | 4.1% | +8.8% |
| Quarter to 31 Dec 2025 | 3.93 | Rs 4.4 bn | Rs 171.2 m | 3.9% | — |
| Quarter to 30 Sep 2025 | 4.20 | Rs 3.9 bn | Rs 182.4 m | 4.7% | — |
| Quarter to 31 Mar 2025 | 3.18 | Rs 3.8 bn | Rs 138.1 m | 3.7% | — |
Cash flow
Where the cash came from and went
| Profit after tax | Rs 650.9 m |
| Depreciation and amortisation | Rs 646.8 m |
| Operating cash flow | Rs 574.9 m |
| Capital spending | Rs -574.6 m |
| Free cashworked out: operating cash flow less capital spending | Rs 277 thousand |
| Dividends paid | Rs -167.9 m |
| Change in cash | Rs -179.9 m |
| Cash at the start of the year | Rs -187.5 m |
| Cash at the end of the year | Rs -367.4 m |
Company accounts, year to 30 Jun 2026 · filed annual report, page 94
Debt
Borrowings and cash
Interest covered by operating profit: Rs 1.4 bn against Rs 318.5 m, 4.4 times
Company accounts, year to 30 Jun 2026 · filed annual report, page 94
More on FEROZ
- FEROZ share price and overview
- FEROZ dividend history
- Pharmaceuticals sector
- GLAXO financials · GlaxoSmithKline Pakistan Limited
- HALEON financials · Haleon Pakistan Limited
- ABOT financials · Abbott Laboratories (Pakistan) Limited
- HINOON financials · Highnoon Laboratories Limited
- SEARL financials · The Searle Company Limited
Data from PSX via SuperX, delayed and provided for information only — not investment advice. Figures may contain errors; verify with your broker before acting. As of .